Posts Tagged ‘reducing’
Reducing dosage of Parkinson’s drugs can cause symptoms similar to those of cocaine withdrawal
New research has shown that reducing the dosage of dopamine agonist drugs, a mainstay treatment for Parkinson’s disease, sometimes causes acute withdrawal symptoms similar to those reported by cocaine addicts, including anxiety, panic attacks, depression, sweating, nausea, generalized pain, fatigue, dizziness and drug cravings. These symptoms can be severe, and are not alleviated by other PD medications. For the first time, researchers have defined this phenomenon, which they call dopamine agonist withdrawal syndrome, or DAWS.
Radiofrequency Ablation Safe And Effective For Reducing Pain From Bone Metastases
Image-guided radiofrequency ablation (RFA), a minimally invasive cancer treatment which can be performed in the outpatient setting, significantly reduced the level of pain experienced by cancer patients with bone (osseous) metastases, limiting the need for strong narcotic pain management, and supporting improved patient frame of mind, according to results of an American College…
Radiofrequency ablation safe and effective for reducing pain from bone metastases, study suggests
Image-guided radiofrequency ablation (RFA), a minimally invasive cancer treatment which can be performed in the outpatient setting, significantly reduced the level of pain experienced by cancer patients with bone (osseous) metastases, limiting the need for strong narcotic pain management, and supporting improved patient frame of mind, according to new results.
BioElectronics Technology More Effective Than Extra Strength Tylenol(R) In Reducing Muscle Soreness In Clinical Study
BioElectronics Corp. (PINKSHEETS: BIEL) announced that its disposable drug-free anti-inflammatory devices proved to be significantly more effective than acetaminophen in a clinical study of Delayed Onset Muscle Soreness (DOMS). The study tested the effectiveness of ActiPatch® Therapy versus acetaminophen in reducing the pain of Delayed Onset Muscle Soreness, a condition associated with increased physical exertion.
Combined Drug Treatment More Effective Than Either Alone At Reducing Neuropathic Pain
Combination treatment using gabapentin and nortriptyline reduces neuropathic pain more than either drug alone, and thus could be used in patients that only partially respond to one drug or the other. These are the conclusions of an Article published Online First (http://www.thelancet.com) and in an upcoming edition of The Lancet.
Promising Results In Reducing Neuropathic Pain With Combined Drug Treatment, Than With Either Drug Alone
An article published Online First and in a future edition of The Lancet reports that combination treatment using gabapentin and nortriptyline reduces neuropathic pain more than either drug alone. This treatment could be used in patients that only partly respond to one drug or the other. The article is the work of Professor Ian Gilron, Director of Clinical Pain Research, Queen’s University, and Kingston General Hospital, Kingston, Ontario, Canada, and colleagues.
Strategies For Reducing Painful Breast Cancer Drug Side Effects
New research has identified patterns that may help breast cancer patients at risk of serious joint pain from aromatase inhibitors. In a recent study, researchers found that estrogen withdrawal may play a role in the onset of arthralgia during treatment: Women who stopped getting their menstrual periods less than five years before starting breast cancer treatment were three times more likely to experience these pains than those who reached menopause earlier.
Study Explores Possibilities Of Reducing Mortality During Spinal Infusion Of Opioids
After evaluating a cluster of deaths most likely related to intrathecal (spinal) opioid infusions in non-cancer pain patients, a group of researchers is confident that such future complications are preventable. In 2006, Medtronic, Inc. and a team of noted experts investigated what might have caused the deaths of three patients early on in their treatment of pain using intrathecal infusion pumps containing opioids.
MOC-Etomidate: Retaining Beneficial Anesthetic Properties, Reducing Dangerous Side Effects
Researchers at Massachusetts General Hospital (MGH) have developed a new anesthetic agent, which they think could be a breakthrough in the quest to discover drugs that retain beneficial anesthetic properties while reducing unwanted and occasionally dangerous side effects. Douglas E. Raines, M.D., and his colleagues from the MGH Department of Anesthesia, Critical Care and Pain Medicine believe that the new drug, MOC-etomidate, could prove to be beneficial for many surgical patients.
Reducing Drug Side-Effects In Pain Relief: New Research
They are a group of drugs which millions of people rely on to keep pain at bay but they can have unwanted side-effects which are sometimes more serious than the original health problem. Now scientists at The University of Nottingham are taking part in the largest-ever study on the safety of Non-Steroidal Anti-Inflammatory Drugs (NSAIDS) that has ever been performed.
Rx Drug Compare
Translator
By N2H